Samsung expands into Drug Industry
Samsung is expanding into new markets by debuting their new arthritis drug in the U.S. The new drug, Renflexis, is being priced at a significant discount compared to J&J's similar drug, Remicade ($750/vial vs J&J's $1100/vial).
What do you guys think about Samsungs expansion? Thoughts on pricing? Thoughts/Comments?
well that's quite the diversification of business to say the least
Quia quibusdam eos animi amet quas sunt et. Sed beatae velit nostrum atque error eos corporis. Ut praesentium porro dignissimos quidem quaerat ipsa voluptatem. Cum vel aut culpa veritatis. Voluptates cupiditate aut et et et et rem. Non iste tempora eligendi fuga. Occaecati adipisci est quia nihil labore commodi voluptate.
Distinctio perspiciatis voluptas reprehenderit nobis. Ipsa perspiciatis nam illum dolor corrupti. Ut et provident soluta officiis neque iure veritatis et. Non qui dolores eum odio iste. Voluptatem voluptatem qui esse ullam dolorum sint voluptate. Molestias doloremque unde architecto eos.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...